Importance The prevalence of and mortality associated with methamphetamine use has
doubled during the past 10 years. There is evidence suggesting that methamphetamine use …

Drug, alcohol and tobacco use disorders are a global burden affecting millions of people.
Despite decades of research, treatment options are sparse or missing, and relapse rates are …

Background Methamphetamine (METH) use is on the rise globally, with the number of
treatment seekers increasing exponentially across the globe. Evidence-based therapies are …

Background Iboga and its primary alkaloids, ibogaine and noribogaine, have been of
interest to researchers and practitioners, mainly due to their putative efficacy in treating …

Abstract Background and Aims There is currently no standard of care for pharmacological
treatment of amphetamine‐type stimulant (ATS) use disorder (ATSUD). This systematic …

Introduction: Amphetamine-type stimulants (ATS) use is a global concern due to increased
usage and the harm to physical, mental, and social well-being. The objective of this …

Rationale Therapeutic communities (TC) for alcohol and other drug treatment rely strongly
on social factors as agents of recovery; an approach known as 'community-as-method'. This …

Methamphetamine is a potent and highly addictive psychostimulant, and one of the most
widely used illicit drugs. Over recent years, its global usage and seizure have been on a …

Substance use disorders are chronic, relapsing, and harmful conditions characterized by
executive dysfunction. While there are currently no approved pharmacotherapy options for …

Background Regular methamphetamine use is associated with increased rates of
psychiatric symptoms. Although there has been a substantial body of research reporting on …